chr4-15574128-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378615.1(CC2D2A):​c.3595-22C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.283 in 1,514,516 control chromosomes in the GnomAD database, including 62,265 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 5625 hom., cov: 32)
Exomes 𝑓: 0.29 ( 56640 hom. )

Consequence

CC2D2A
NM_001378615.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.509

Publications

9 publications found
Variant links:
Genes affected
CC2D2A (HGNC:29253): (coiled-coil and C2 domain containing 2A) This gene encodes a coiled-coil and calcium binding domain protein that appears to play a critical role in cilia formation. Mutations in this gene cause Meckel syndrome type 6, as well as Joubert syndrome type 9. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
CC2D2A Gene-Disease associations (from GenCC):
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Joubert syndrome 9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • retinitis pigmentosa 93
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • COACH syndrome 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with oculorenal defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 4-15574128-C-T is Benign according to our data. Variant chr4-15574128-C-T is described in ClinVar as Benign. ClinVar VariationId is 126241.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.444 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CC2D2ANM_001378615.1 linkc.3595-22C>T intron_variant Intron 28 of 36 ENST00000424120.6 NP_001365544.1
CC2D2ANM_001080522.2 linkc.3595-22C>T intron_variant Intron 29 of 37 NP_001073991.2 Q9P2K1-4
CC2D2ANM_001378617.1 linkc.3448-22C>T intron_variant Intron 26 of 34 NP_001365546.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CC2D2AENST00000424120.6 linkc.3595-22C>T intron_variant Intron 28 of 36 5 NM_001378615.1 ENSP00000403465.1 Q9P2K1-4

Frequencies

GnomAD3 genomes
AF:
0.267
AC:
40567
AN:
151996
Hom.:
5609
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.224
Gnomad AMI
AF:
0.133
Gnomad AMR
AF:
0.224
Gnomad ASJ
AF:
0.265
Gnomad EAS
AF:
0.459
Gnomad SAS
AF:
0.293
Gnomad FIN
AF:
0.321
Gnomad MID
AF:
0.287
Gnomad NFE
AF:
0.279
Gnomad OTH
AF:
0.283
GnomAD2 exomes
AF:
0.284
AC:
39296
AN:
138486
AF XY:
0.288
show subpopulations
Gnomad AFR exome
AF:
0.219
Gnomad AMR exome
AF:
0.202
Gnomad ASJ exome
AF:
0.285
Gnomad EAS exome
AF:
0.476
Gnomad FIN exome
AF:
0.317
Gnomad NFE exome
AF:
0.283
Gnomad OTH exome
AF:
0.267
GnomAD4 exome
AF:
0.285
AC:
388598
AN:
1362402
Hom.:
56640
Cov.:
26
AF XY:
0.285
AC XY:
190631
AN XY:
669424
show subpopulations
African (AFR)
AF:
0.226
AC:
6879
AN:
30388
American (AMR)
AF:
0.205
AC:
6619
AN:
32364
Ashkenazi Jewish (ASJ)
AF:
0.279
AC:
6671
AN:
23948
East Asian (EAS)
AF:
0.434
AC:
15236
AN:
35088
South Asian (SAS)
AF:
0.285
AC:
21386
AN:
75090
European-Finnish (FIN)
AF:
0.318
AC:
15434
AN:
48562
Middle Eastern (MID)
AF:
0.276
AC:
1234
AN:
4474
European-Non Finnish (NFE)
AF:
0.283
AC:
298674
AN:
1056164
Other (OTH)
AF:
0.292
AC:
16465
AN:
56324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
12598
25195
37793
50390
62988
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10276
20552
30828
41104
51380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.267
AC:
40602
AN:
152114
Hom.:
5625
Cov.:
32
AF XY:
0.271
AC XY:
20120
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.224
AC:
9286
AN:
41520
American (AMR)
AF:
0.224
AC:
3424
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.265
AC:
918
AN:
3470
East Asian (EAS)
AF:
0.459
AC:
2373
AN:
5166
South Asian (SAS)
AF:
0.294
AC:
1416
AN:
4820
European-Finnish (FIN)
AF:
0.321
AC:
3398
AN:
10574
Middle Eastern (MID)
AF:
0.301
AC:
88
AN:
292
European-Non Finnish (NFE)
AF:
0.279
AC:
18970
AN:
67974
Other (OTH)
AF:
0.289
AC:
608
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1553
3106
4659
6212
7765
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.274
Hom.:
1102
Bravo
AF:
0.257
Asia WGS
AF:
0.344
AC:
1197
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Meckel syndrome, type 6 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Joubert syndrome 9 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
13
DANN
Benign
0.83
PhyloP100
0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4280724; hg19: chr4-15575751; COSMIC: COSV67503626; API